To include your compound in the COVID-19 Resource Center, submit it here.

IL-7: Phase IIa started

Cytheris, Centre Leon Berard (Lyon, France) and ImmunID S.A.S. (Grenoble, France) began the double-blind,

Read the full 145 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE